Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

A new treatment called deucravacitinib helped a patient with severe hair loss grow their hair back quickly.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

UVFT helps diagnose hair and scalp diseases by showing different fluorescence patterns.

Exosomes may help with hair growth and scar healing, but more research is needed.

Exosomes are important for skin treatments and hair growth but need more research for safe and effective use.

Clascoterone cream effectively reduces acne severity and is safe for patients 12 and older.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Lupus nephritis patients face more challenges in family planning, work, symptoms, medication, and quality of life than those without it.

The algorithm accurately identified alopecia in women of childbearing age using claims data.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Minoxidil improved hair growth in a child with a rare genetic disorder.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Sunlight exposure damages hair follicles, but certain stem cell-derived particles can reduce this damage and help with hair regeneration.

Refugee patients face long wait times for dermatology care, worsening health disparities.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.